nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—ABCB1—Desloratadine—allergic rhinitis	0.0895	0.211	CbGbCtD
Afatinib—ABCG2—Hydrocortisone—allergic rhinitis	0.0793	0.187	CbGbCtD
Afatinib—ABCB1—Loratadine—allergic rhinitis	0.0514	0.121	CbGbCtD
Afatinib—ABCG2—Dexamethasone—allergic rhinitis	0.0493	0.116	CbGbCtD
Afatinib—ABCB1—Methylprednisolone—allergic rhinitis	0.047	0.111	CbGbCtD
Afatinib—ABCB1—Betamethasone—allergic rhinitis	0.0306	0.0722	CbGbCtD
Afatinib—ABCB1—Prednisolone—allergic rhinitis	0.0302	0.0712	CbGbCtD
Afatinib—ABCB1—Hydrocortisone—allergic rhinitis	0.0286	0.0675	CbGbCtD
Afatinib—ABCB1—Dexamethasone—allergic rhinitis	0.0178	0.042	CbGbCtD
Afatinib—ERBB2—exocrine gland—allergic rhinitis	0.0121	0.128	CbGeAlD
Afatinib—ERBB2—respiratory system—allergic rhinitis	0.00628	0.0664	CbGeAlD
Afatinib—ERBB4—respiratory system—allergic rhinitis	0.00628	0.0664	CbGeAlD
Afatinib—DYRK1A—respiratory system—allergic rhinitis	0.00604	0.0639	CbGeAlD
Afatinib—ERBB2—epithelium—allergic rhinitis	0.00524	0.0555	CbGeAlD
Afatinib—ERBB4—epithelium—allergic rhinitis	0.00524	0.0555	CbGeAlD
Afatinib—ERBB2—skin of body—allergic rhinitis	0.00499	0.0528	CbGeAlD
Afatinib—IRAK1—bronchus—allergic rhinitis	0.00386	0.0409	CbGeAlD
Afatinib—LCK—bronchus—allergic rhinitis	0.00377	0.0399	CbGeAlD
Afatinib—PHKG2—lung—allergic rhinitis	0.00371	0.0392	CbGeAlD
Afatinib—LCK—trachea—allergic rhinitis	0.00338	0.0358	CbGeAlD
Afatinib—ERBB2—lung—allergic rhinitis	0.00333	0.0353	CbGeAlD
Afatinib—ERBB4—lung—allergic rhinitis	0.00333	0.0353	CbGeAlD
Afatinib—DYRK1A—lung—allergic rhinitis	0.00321	0.0339	CbGeAlD
Afatinib—EGFR—lung—allergic rhinitis	0.00282	0.0299	CbGeAlD
Afatinib—ABL1—respiratory system—allergic rhinitis	0.00263	0.0278	CbGeAlD
Afatinib—IRAK1—lung—allergic rhinitis	0.00249	0.0264	CbGeAlD
Afatinib—LCK—lung—allergic rhinitis	0.00243	0.0257	CbGeAlD
Afatinib—ABL1—eye—allergic rhinitis	0.0024	0.0254	CbGeAlD
Afatinib—ABL1—bronchus—allergic rhinitis	0.00216	0.0229	CbGeAlD
Afatinib—ABL1—skin of body—allergic rhinitis	0.00209	0.0221	CbGeAlD
Afatinib—ABL1—trachea—allergic rhinitis	0.00194	0.0206	CbGeAlD
Afatinib—ABL1—lung—allergic rhinitis	0.0014	0.0148	CbGeAlD
Afatinib—ERBB2—Triamcinolone—Flunisolide—allergic rhinitis	0.00106	0.11	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Flunisolide—allergic rhinitis	0.00101	0.105	CbGdCrCtD
Afatinib—ERBB2—Exemestane—Methylprednisolone—allergic rhinitis	0.000952	0.099	CbGdCrCtD
Afatinib—Urethral disorder—Montelukast—allergic rhinitis	0.000945	0.00301	CcSEcCtD
Afatinib—Cough—Loratadine—allergic rhinitis	0.000928	0.00296	CcSEcCtD
Afatinib—Diarrhoea—Desloratadine—allergic rhinitis	0.000922	0.00294	CcSEcCtD
Afatinib—Dizziness—Cyproheptadine—allergic rhinitis	0.000916	0.00292	CcSEcCtD
Afatinib—Body temperature increased—Olopatadine—allergic rhinitis	0.00091	0.0029	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Loratadine—allergic rhinitis	0.000899	0.00286	CcSEcCtD
Afatinib—Dizziness—Desloratadine—allergic rhinitis	0.000891	0.00284	CcSEcCtD
Afatinib—Vomiting—Cyproheptadine—allergic rhinitis	0.000881	0.00281	CcSEcCtD
Afatinib—ABCG2—lung—allergic rhinitis	0.00088	0.00932	CbGeAlD
Afatinib—Rash—Cyproheptadine—allergic rhinitis	0.000874	0.00278	CcSEcCtD
Afatinib—Cough—Cetirizine—allergic rhinitis	0.000873	0.00278	CcSEcCtD
Afatinib—Dermatitis—Cyproheptadine—allergic rhinitis	0.000873	0.00278	CcSEcCtD
Afatinib—Mediastinal disorder—Montelukast—allergic rhinitis	0.000869	0.00277	CcSEcCtD
Afatinib—Headache—Cyproheptadine—allergic rhinitis	0.000868	0.00277	CcSEcCtD
Afatinib—Cough—Flunisolide—allergic rhinitis	0.000859	0.00274	CcSEcCtD
Afatinib—Vomiting—Desloratadine—allergic rhinitis	0.000857	0.00273	CcSEcCtD
Afatinib—Nervous system disorder—Loratadine—allergic rhinitis	0.000851	0.00271	CcSEcCtD
Afatinib—Rash—Desloratadine—allergic rhinitis	0.000849	0.00271	CcSEcCtD
Afatinib—Dermatitis—Desloratadine—allergic rhinitis	0.000849	0.0027	CcSEcCtD
Afatinib—ERBB2—Exemestane—Prednisolone—allergic rhinitis	0.000848	0.0882	CbGdCrCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Cetirizine—allergic rhinitis	0.000846	0.0027	CcSEcCtD
Afatinib—Mental disorder—Montelukast—allergic rhinitis	0.000845	0.00269	CcSEcCtD
Afatinib—Headache—Desloratadine—allergic rhinitis	0.000844	0.00269	CcSEcCtD
Afatinib—Skin disorder—Loratadine—allergic rhinitis	0.000843	0.00269	CcSEcCtD
Afatinib—Asthenia—Olopatadine—allergic rhinitis	0.000826	0.00263	CcSEcCtD
Afatinib—Nausea—Cyproheptadine—allergic rhinitis	0.000823	0.00262	CcSEcCtD
Afatinib—Dry eye—Dexamethasone—allergic rhinitis	0.000818	0.00261	CcSEcCtD
Afatinib—Dry eye—Betamethasone—allergic rhinitis	0.000818	0.00261	CcSEcCtD
Afatinib—ABCB1—respiratory system—allergic rhinitis	0.000818	0.00865	CbGeAlD
Afatinib—Pruritus—Olopatadine—allergic rhinitis	0.000815	0.0026	CcSEcCtD
Afatinib—Infection—Cetirizine—allergic rhinitis	0.000811	0.00258	CcSEcCtD
Afatinib—Asthenia—Dimenhydrinate—allergic rhinitis	0.000809	0.00258	CcSEcCtD
Afatinib—Asthenia—Diphenhydramine—allergic rhinitis	0.000809	0.00258	CcSEcCtD
Afatinib—Muscle spasms—Montelukast—allergic rhinitis	0.000807	0.00257	CcSEcCtD
Afatinib—Nervous system disorder—Cetirizine—allergic rhinitis	0.000801	0.00255	CcSEcCtD
Afatinib—Nausea—Desloratadine—allergic rhinitis	0.0008	0.00255	CcSEcCtD
Afatinib—Infection—Flunisolide—allergic rhinitis	0.000798	0.00254	CcSEcCtD
Afatinib—Skin disorder—Cetirizine—allergic rhinitis	0.000793	0.00253	CcSEcCtD
Afatinib—Diarrhoea—Olopatadine—allergic rhinitis	0.000788	0.00251	CcSEcCtD
Afatinib—Insomnia—Loratadine—allergic rhinitis	0.000785	0.0025	CcSEcCtD
Afatinib—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000771	0.00246	CcSEcCtD
Afatinib—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000771	0.00246	CcSEcCtD
Afatinib—Dyspepsia—Loratadine—allergic rhinitis	0.000764	0.00243	CcSEcCtD
Afatinib—Dizziness—Olopatadine—allergic rhinitis	0.000762	0.00243	CcSEcCtD
Afatinib—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000749	0.00239	CcSEcCtD
Afatinib—Fatigue—Loratadine—allergic rhinitis	0.000748	0.00238	CcSEcCtD
Afatinib—Dizziness—Dimenhydrinate—allergic rhinitis	0.000745	0.00237	CcSEcCtD
Afatinib—Dizziness—Diphenhydramine—allergic rhinitis	0.000745	0.00237	CcSEcCtD
Afatinib—Constipation—Loratadine—allergic rhinitis	0.000742	0.00236	CcSEcCtD
Afatinib—Insomnia—Cetirizine—allergic rhinitis	0.000739	0.00235	CcSEcCtD
Afatinib—Cough—Montelukast—allergic rhinitis	0.000732	0.00233	CcSEcCtD
Afatinib—Vomiting—Olopatadine—allergic rhinitis	0.000732	0.00233	CcSEcCtD
Afatinib—Dyspnoea—Cetirizine—allergic rhinitis	0.000728	0.00232	CcSEcCtD
Afatinib—Insomnia—Flunisolide—allergic rhinitis	0.000726	0.00231	CcSEcCtD
Afatinib—Rash—Olopatadine—allergic rhinitis	0.000726	0.00231	CcSEcCtD
Afatinib—Dermatitis—Olopatadine—allergic rhinitis	0.000726	0.00231	CcSEcCtD
Afatinib—Headache—Olopatadine—allergic rhinitis	0.000722	0.0023	CcSEcCtD
Afatinib—Dyspepsia—Cetirizine—allergic rhinitis	0.000719	0.00229	CcSEcCtD
Afatinib—Vomiting—Diphenhydramine—allergic rhinitis	0.000717	0.00228	CcSEcCtD
Afatinib—Vomiting—Dimenhydrinate—allergic rhinitis	0.000717	0.00228	CcSEcCtD
Afatinib—Dyspnoea—Flunisolide—allergic rhinitis	0.000716	0.00228	CcSEcCtD
Afatinib—Rash—Diphenhydramine—allergic rhinitis	0.000711	0.00226	CcSEcCtD
Afatinib—Rash—Dimenhydrinate—allergic rhinitis	0.000711	0.00226	CcSEcCtD
Afatinib—Decreased appetite—Cetirizine—allergic rhinitis	0.00071	0.00226	CcSEcCtD
Afatinib—Dermatitis—Diphenhydramine—allergic rhinitis	0.00071	0.00226	CcSEcCtD
Afatinib—Dermatitis—Dimenhydrinate—allergic rhinitis	0.00071	0.00226	CcSEcCtD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.00071	0.00226	CcSEcCtD
Afatinib—Dyspepsia—Flunisolide—allergic rhinitis	0.000707	0.00225	CcSEcCtD
Afatinib—Dry skin—Prednisolone—allergic rhinitis	0.000706	0.00225	CcSEcCtD
Afatinib—Headache—Diphenhydramine—allergic rhinitis	0.000706	0.00225	CcSEcCtD
Afatinib—Headache—Dimenhydrinate—allergic rhinitis	0.000706	0.00225	CcSEcCtD
Afatinib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000705	0.00225	CcSEcCtD
Afatinib—Fatigue—Cetirizine—allergic rhinitis	0.000704	0.00224	CcSEcCtD
Afatinib—Constipation—Cetirizine—allergic rhinitis	0.000698	0.00222	CcSEcCtD
Afatinib—Decreased appetite—Flunisolide—allergic rhinitis	0.000698	0.00222	CcSEcCtD
Afatinib—Fatigue—Flunisolide—allergic rhinitis	0.000692	0.00221	CcSEcCtD
Afatinib—Dry skin—Hydrocortisone—allergic rhinitis	0.00069	0.0022	CcSEcCtD
Afatinib—Constipation—Flunisolide—allergic rhinitis	0.000687	0.00219	CcSEcCtD
Afatinib—Body temperature increased—Loratadine—allergic rhinitis	0.000686	0.00219	CcSEcCtD
Afatinib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000685	0.00218	CcSEcCtD
Afatinib—Nausea—Olopatadine—allergic rhinitis	0.000684	0.00218	CcSEcCtD
Afatinib—ABCB1—epithelium—allergic rhinitis	0.000683	0.00723	CbGeAlD
Afatinib—Infection—Montelukast—allergic rhinitis	0.00068	0.00217	CcSEcCtD
Afatinib—Nervous system disorder—Montelukast—allergic rhinitis	0.000672	0.00214	CcSEcCtD
Afatinib—Nausea—Dimenhydrinate—allergic rhinitis	0.000669	0.00213	CcSEcCtD
Afatinib—Nausea—Diphenhydramine—allergic rhinitis	0.000669	0.00213	CcSEcCtD
Afatinib—Skin disorder—Montelukast—allergic rhinitis	0.000665	0.00212	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000664	0.00211	CcSEcCtD
Afatinib—Body temperature increased—Cetirizine—allergic rhinitis	0.000646	0.00206	CcSEcCtD
Afatinib—Body temperature increased—Flunisolide—allergic rhinitis	0.000635	0.00202	CcSEcCtD
Afatinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000624	0.00199	CcSEcCtD
Afatinib—Asthenia—Loratadine—allergic rhinitis	0.000623	0.00198	CcSEcCtD
Afatinib—Insomnia—Montelukast—allergic rhinitis	0.000619	0.00197	CcSEcCtD
Afatinib—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000604	0.00193	CcSEcCtD
Afatinib—ABCB1—trachea—allergic rhinitis	0.000604	0.00639	CbGeAlD
Afatinib—Dyspepsia—Montelukast—allergic rhinitis	0.000603	0.00192	CcSEcCtD
Afatinib—Diarrhoea—Loratadine—allergic rhinitis	0.000594	0.00189	CcSEcCtD
Afatinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000591	0.00188	CcSEcCtD
Afatinib—Fatigue—Montelukast—allergic rhinitis	0.000591	0.00188	CcSEcCtD
Afatinib—Dry skin—Betamethasone—allergic rhinitis	0.000589	0.00188	CcSEcCtD
Afatinib—Dry skin—Dexamethasone—allergic rhinitis	0.000589	0.00188	CcSEcCtD
Afatinib—Weight decreased—Hydrocortisone—allergic rhinitis	0.000588	0.00187	CcSEcCtD
Afatinib—Asthenia—Cetirizine—allergic rhinitis	0.000586	0.00187	CcSEcCtD
Afatinib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000585	0.00186	CcSEcCtD
Afatinib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000585	0.00186	CcSEcCtD
Afatinib—Infestation—Hydrocortisone—allergic rhinitis	0.00058	0.00185	CcSEcCtD
Afatinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.00058	0.00185	CcSEcCtD
Afatinib—Pruritus—Cetirizine—allergic rhinitis	0.000578	0.00184	CcSEcCtD
Afatinib—Conjunctivitis—Prednisolone—allergic rhinitis	0.000577	0.00184	CcSEcCtD
Afatinib—Asthenia—Flunisolide—allergic rhinitis	0.000576	0.00184	CcSEcCtD
Afatinib—Dizziness—Loratadine—allergic rhinitis	0.000574	0.00183	CcSEcCtD
Afatinib—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000569	0.00181	CcSEcCtD
Afatinib—Pruritus—Flunisolide—allergic rhinitis	0.000568	0.00181	CcSEcCtD
Afatinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000559	0.00178	CcSEcCtD
Afatinib—Vomiting—Loratadine—allergic rhinitis	0.000552	0.00176	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Hydrocortisone—allergic rhinitis	0.00055	0.0571	CbGdCrCtD
Afatinib—Diarrhoea—Flunisolide—allergic rhinitis	0.000549	0.00175	CcSEcCtD
Afatinib—Rash—Loratadine—allergic rhinitis	0.000547	0.00174	CcSEcCtD
Afatinib—Dermatitis—Loratadine—allergic rhinitis	0.000547	0.00174	CcSEcCtD
Afatinib—Infestation—Methylprednisolone—allergic rhinitis	0.000545	0.00174	CcSEcCtD
Afatinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000545	0.00174	CcSEcCtD
Afatinib—Headache—Loratadine—allergic rhinitis	0.000544	0.00173	CcSEcCtD
Afatinib—Body temperature increased—Montelukast—allergic rhinitis	0.000541	0.00172	CcSEcCtD
Afatinib—Dizziness—Cetirizine—allergic rhinitis	0.00054	0.00172	CcSEcCtD
Afatinib—Dizziness—Flunisolide—allergic rhinitis	0.000531	0.00169	CcSEcCtD
Afatinib—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000531	0.00169	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Hydrocortisone—allergic rhinitis	0.000522	0.0543	CbGdCrCtD
Afatinib—Vomiting—Cetirizine—allergic rhinitis	0.000519	0.00165	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Methylprednisolone—allergic rhinitis	0.000519	0.0539	CbGdCrCtD
Afatinib—Nausea—Loratadine—allergic rhinitis	0.000516	0.00164	CcSEcCtD
Afatinib—Epistaxis—Triamcinolone—allergic rhinitis	0.000515	0.00164	CcSEcCtD
Afatinib—Rash—Cetirizine—allergic rhinitis	0.000515	0.00164	CcSEcCtD
Afatinib—Dermatitis—Cetirizine—allergic rhinitis	0.000515	0.00164	CcSEcCtD
Afatinib—Headache—Cetirizine—allergic rhinitis	0.000512	0.00163	CcSEcCtD
Afatinib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000512	0.00163	CcSEcCtD
Afatinib—Vomiting—Flunisolide—allergic rhinitis	0.000511	0.00163	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Betamethasone—allergic rhinitis	0.000511	0.0531	CbGdCrCtD
Afatinib—ERBB2—Triamcinolone—Dexamethasone—allergic rhinitis	0.000511	0.0531	CbGdCrCtD
Afatinib—Rash—Flunisolide—allergic rhinitis	0.000506	0.00161	CcSEcCtD
Afatinib—Dermatitis—Flunisolide—allergic rhinitis	0.000506	0.00161	CcSEcCtD
Afatinib—Headache—Flunisolide—allergic rhinitis	0.000503	0.0016	CcSEcCtD
Afatinib—Weight decreased—Dexamethasone—allergic rhinitis	0.000503	0.0016	CcSEcCtD
Afatinib—Weight decreased—Betamethasone—allergic rhinitis	0.000503	0.0016	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Methylprednisolone—allergic rhinitis	0.000493	0.0512	CbGdCrCtD
Afatinib—Asthenia—Montelukast—allergic rhinitis	0.000491	0.00157	CcSEcCtD
Afatinib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000487	0.00155	CcSEcCtD
Afatinib—Nausea—Cetirizine—allergic rhinitis	0.000485	0.00155	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Dexamethasone—allergic rhinitis	0.000485	0.0504	CbGdCrCtD
Afatinib—ERBB2—Desoximetasone—Betamethasone—allergic rhinitis	0.000485	0.0504	CbGdCrCtD
Afatinib—Pruritus—Montelukast—allergic rhinitis	0.000485	0.00154	CcSEcCtD
Afatinib—Conjunctivitis—Betamethasone—allergic rhinitis	0.000482	0.00153	CcSEcCtD
Afatinib—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000482	0.00153	CcSEcCtD
Afatinib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000481	0.00153	CcSEcCtD
Afatinib—Nausea—Flunisolide—allergic rhinitis	0.000477	0.00152	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Triamcinolone—allergic rhinitis	0.000474	0.0492	CbGdCrCtD
Afatinib—Diarrhoea—Montelukast—allergic rhinitis	0.000469	0.00149	CcSEcCtD
Afatinib—ERBB2—Triamcinolone—Prednisolone—allergic rhinitis	0.000462	0.048	CbGdCrCtD
Afatinib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000457	0.00146	CcSEcCtD
Afatinib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000456	0.00145	CcSEcCtD
Afatinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000453	0.00144	CcSEcCtD
Afatinib—Dizziness—Montelukast—allergic rhinitis	0.000453	0.00144	CcSEcCtD
Afatinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000441	0.0014	CcSEcCtD
Afatinib—ERBB2—Desoximetasone—Prednisolone—allergic rhinitis	0.000439	0.0456	CbGdCrCtD
Afatinib—Vomiting—Montelukast—allergic rhinitis	0.000435	0.00139	CcSEcCtD
Afatinib—ABCB1—lung—allergic rhinitis	0.000434	0.00459	CbGeAlD
Afatinib—Rash—Montelukast—allergic rhinitis	0.000432	0.00138	CcSEcCtD
Afatinib—Dermatitis—Montelukast—allergic rhinitis	0.000431	0.00137	CcSEcCtD
Afatinib—Headache—Montelukast—allergic rhinitis	0.000429	0.00137	CcSEcCtD
Afatinib—Mental disorder—Methylprednisolone—allergic rhinitis	0.000429	0.00136	CcSEcCtD
Afatinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000426	0.00136	CcSEcCtD
Afatinib—Dysgeusia—Triamcinolone—allergic rhinitis	0.000418	0.00133	CcSEcCtD
Afatinib—Eye disorder—Betamethasone—allergic rhinitis	0.000416	0.00132	CcSEcCtD
Afatinib—Eye disorder—Dexamethasone—allergic rhinitis	0.000416	0.00132	CcSEcCtD
Afatinib—Back pain—Triamcinolone—allergic rhinitis	0.000413	0.00131	CcSEcCtD
Afatinib—Nausea—Montelukast—allergic rhinitis	0.000407	0.0013	CcSEcCtD
Afatinib—Alopecia—Betamethasone—allergic rhinitis	0.000393	0.00125	CcSEcCtD
Afatinib—Alopecia—Dexamethasone—allergic rhinitis	0.000393	0.00125	CcSEcCtD
Afatinib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000383	0.00242	CbGpPWpGaD
Afatinib—IRAK1—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000383	0.00242	CbGpPWpGaD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000383	0.00122	CcSEcCtD
Afatinib—ERBB2—Adaptive Immune System—HLA-G—allergic rhinitis	0.000381	0.00241	CbGpPWpGaD
Afatinib—IRAK1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	0.00038	0.0024	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—CD4—allergic rhinitis	0.000379	0.00239	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—HLA-G—allergic rhinitis	0.000376	0.00237	CbGpPWpGaD
Afatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—allergic rhinitis	0.000375	0.00237	CbGpPWpGaD
Afatinib—IRAK1—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	0.000373	0.00235	CbGpPWpGaD
Afatinib—Cough—Triamcinolone—allergic rhinitis	0.000372	0.00119	CcSEcCtD
Afatinib—Infection—Hydrocortisone—allergic rhinitis	0.000367	0.00117	CcSEcCtD
Afatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000367	0.00232	CbGpPWpGaD
Afatinib—IRAK1—Apoptosis Modulation and Signaling—NFKB1—allergic rhinitis	0.000363	0.00229	CbGpPWpGaD
Afatinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000363	0.00116	CcSEcCtD
Afatinib—ERBB2—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	0.000362	0.00228	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—HLA-G—allergic rhinitis	0.000361	0.00228	CbGpPWpGaD
Afatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.00036	0.00115	CcSEcCtD
Afatinib—IRAK1—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	0.00036	0.00227	CbGpPWpGaD
Afatinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000359	0.00114	CcSEcCtD
Afatinib—ABL1—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000358	0.00226	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MS4A2—allergic rhinitis	0.000356	0.00224	CbGpPWpGaD
Afatinib—IRAK1—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	0.000354	0.00223	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000351	0.00222	CbGpPWpGaD
Afatinib—LCK—TCR signaling in naïve CD4+ T cells—CD4—allergic rhinitis	0.000351	0.00222	CbGpPWpGaD
Afatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000349	0.0022	CbGpPWpGaD
Afatinib—Infection—Triamcinolone—allergic rhinitis	0.000346	0.0011	CcSEcCtD
Afatinib—Infection—Methylprednisolone—allergic rhinitis	0.000345	0.0011	CcSEcCtD
Afatinib—EPHA6—Developmental Biology—SMAD3—allergic rhinitis	0.000345	0.00218	CbGpPWpGaD
Afatinib—LCK—Costimulation by the CD28 family—CD4—allergic rhinitis	0.000343	0.00216	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MS4A2—allergic rhinitis	0.000343	0.00216	CbGpPWpGaD
Afatinib—Insomnia—Prednisolone—allergic rhinitis	0.000343	0.00109	CcSEcCtD
Afatinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000341	0.00109	CcSEcCtD
Afatinib—IRAK1—MyD88-independent cascade—NFKB1—allergic rhinitis	0.000339	0.00214	CbGpPWpGaD
Afatinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000338	0.00108	CcSEcCtD
Afatinib—Insomnia—Hydrocortisone—allergic rhinitis	0.000335	0.00107	CcSEcCtD
Afatinib—IRAK1—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000331	0.00209	CbGpPWpGaD
Afatinib—LCK—TCR signaling—NFKB1—allergic rhinitis	0.000331	0.00209	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.00033	0.00208	CbGpPWpGaD
Afatinib—LCK—IL12-mediated signaling events—NFKB1—allergic rhinitis	0.000326	0.00206	CbGpPWpGaD
Afatinib—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000326	0.00104	CcSEcCtD
Afatinib—LCK—Notch Signaling Pathway—NFKB1—allergic rhinitis	0.000322	0.00203	CbGpPWpGaD
Afatinib—EGFR—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000322	0.00203	CbGpPWpGaD
Afatinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000322	0.00102	CcSEcCtD
Afatinib—LCK—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000321	0.00203	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.00032	0.00202	CbGpPWpGaD
Afatinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000319	0.00102	CcSEcCtD
Afatinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000319	0.00102	CcSEcCtD
Afatinib—IRAK1—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000316	0.002	CbGpPWpGaD
Afatinib—Insomnia—Triamcinolone—allergic rhinitis	0.000315	0.001	CcSEcCtD
Afatinib—Insomnia—Methylprednisolone—allergic rhinitis	0.000314	0.001	CcSEcCtD
Afatinib—Infection—Dexamethasone—allergic rhinitis	0.000314	0.001	CcSEcCtD
Afatinib—Infection—Betamethasone—allergic rhinitis	0.000314	0.001	CcSEcCtD
Afatinib—EGFR—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000314	0.00198	CbGpPWpGaD
Afatinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000312	0.00197	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000311	0.00197	CbGpPWpGaD
Afatinib—Dyspnoea—Triamcinolone—allergic rhinitis	0.00031	0.000989	CcSEcCtD
Afatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	0.00031	0.00196	CbGpPWpGaD
Afatinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.00031	0.000987	CcSEcCtD
Afatinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.00031	0.000987	CcSEcCtD
Afatinib—IRAK1—Immune System—MS4A2—allergic rhinitis	0.00031	0.00196	CbGpPWpGaD
Afatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000309	0.00195	CbGpPWpGaD
Afatinib—Dyspepsia—Triamcinolone—allergic rhinitis	0.000307	0.000976	CcSEcCtD
Afatinib—EGFR—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000306	0.00193	CbGpPWpGaD
Afatinib—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000306	0.000974	CcSEcCtD
Afatinib—ERBB2—Levonorgestrel—Hydrocortisone—allergic rhinitis	0.000305	0.0317	CbGdCrCtD
Afatinib—IRAK1—Activated TLR4 signalling—NFKB1—allergic rhinitis	0.000305	0.00193	CbGpPWpGaD
Afatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000304	0.00192	CbGpPWpGaD
Afatinib—Fatigue—Triamcinolone—allergic rhinitis	0.0003	0.000956	CcSEcCtD
Afatinib—Fatigue—Methylprednisolone—allergic rhinitis	0.0003	0.000954	CcSEcCtD
Afatinib—ABL1—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000299	0.00189	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000297	0.00187	CbGpPWpGaD
Afatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000295	0.00186	CbGpPWpGaD
Afatinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000292	0.000931	CcSEcCtD
Afatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.00029	0.00183	CbGpPWpGaD
Afatinib—LCK—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.000289	0.00183	CbGpPWpGaD
Afatinib—IRAK1—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	0.000287	0.00181	CbGpPWpGaD
Afatinib—Insomnia—Betamethasone—allergic rhinitis	0.000286	0.00091	CcSEcCtD
Afatinib—Insomnia—Dexamethasone—allergic rhinitis	0.000286	0.00091	CcSEcCtD
Afatinib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.00028	0.00177	CbGpPWpGaD
Afatinib—Dyspepsia—Dexamethasone—allergic rhinitis	0.000278	0.000886	CcSEcCtD
Afatinib—Dyspepsia—Betamethasone—allergic rhinitis	0.000278	0.000886	CcSEcCtD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000277	0.00175	CbGpPWpGaD
Afatinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000275	0.000877	CcSEcCtD
Afatinib—Decreased appetite—Betamethasone—allergic rhinitis	0.000275	0.000875	CcSEcCtD
Afatinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000275	0.000875	CcSEcCtD
Afatinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000273	0.000869	CcSEcCtD
Afatinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000273	0.000869	CcSEcCtD
Afatinib—ERBB2—B Cell Activation—NFKB1—allergic rhinitis	0.000273	0.00172	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.000273	0.00172	CbGpPWpGaD
Afatinib—Fatigue—Betamethasone—allergic rhinitis	0.000272	0.000868	CcSEcCtD
Afatinib—Fatigue—Dexamethasone—allergic rhinitis	0.000272	0.000868	CcSEcCtD
Afatinib—ERBB4—B Cell Activation—NFKB1—allergic rhinitis	0.000269	0.0017	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000266	0.00168	CbGpPWpGaD
Afatinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000265	0.000845	CcSEcCtD
Afatinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000262	0.000833	CcSEcCtD
Afatinib—IRAK1—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000259	0.00163	CbGpPWpGaD
Afatinib—BLK—B Cell Activation—NFKB1—allergic rhinitis	0.000258	0.00163	CbGpPWpGaD
Afatinib—IRAK1—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	0.000256	0.00161	CbGpPWpGaD
Afatinib—EGFR—Regulation of Telomerase—TGFB1—allergic rhinitis	0.000255	0.00161	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—SMAD3—allergic rhinitis	0.000255	0.00161	CbGpPWpGaD
Afatinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000253	0.000806	CcSEcCtD
Afatinib—Dizziness—Prednisolone—allergic rhinitis	0.00025	0.000798	CcSEcCtD
Afatinib—Asthenia—Triamcinolone—allergic rhinitis	0.00025	0.000796	CcSEcCtD
Afatinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.00025	0.000796	CcSEcCtD
Afatinib—Body temperature increased—Betamethasone—allergic rhinitis	0.00025	0.000796	CcSEcCtD
Afatinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000249	0.000794	CcSEcCtD
Afatinib—Pruritus—Triamcinolone—allergic rhinitis	0.000246	0.000785	CcSEcCtD
Afatinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000246	0.000783	CcSEcCtD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—NFKB1—allergic rhinitis	0.000246	0.00155	CbGpPWpGaD
Afatinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000245	0.000779	CcSEcCtD
Afatinib—PHKG2—Disease—SMAD3—allergic rhinitis	0.000244	0.00154	CbGpPWpGaD
Afatinib—ABL1—Immune System—MS4A2—allergic rhinitis	0.000242	0.00153	CbGpPWpGaD
Afatinib—Rash—Prednisolone—allergic rhinitis	0.000239	0.000761	CcSEcCtD
Afatinib—Dermatitis—Prednisolone—allergic rhinitis	0.000239	0.00076	CcSEcCtD
Afatinib—ERBB2—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000238	0.0015	CbGpPWpGaD
Afatinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000238	0.000757	CcSEcCtD
Afatinib—Headache—Prednisolone—allergic rhinitis	0.000237	0.000756	CcSEcCtD
Afatinib—ERBB2—Signaling Pathways—PTGDR2—allergic rhinitis	0.000235	0.00149	CbGpPWpGaD
Afatinib—Vomiting—Hydrocortisone—allergic rhinitis	0.000235	0.000749	CcSEcCtD
Afatinib—ERBB4—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000234	0.00148	CbGpPWpGaD
Afatinib—Rash—Hydrocortisone—allergic rhinitis	0.000233	0.000743	CcSEcCtD
Afatinib—IRAK1—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000233	0.00147	CbGpPWpGaD
Afatinib—Dermatitis—Hydrocortisone—allergic rhinitis	0.000233	0.000742	CcSEcCtD
Afatinib—ERBB4—Signaling Pathways—PTGDR2—allergic rhinitis	0.000232	0.00146	CbGpPWpGaD
Afatinib—Headache—Hydrocortisone—allergic rhinitis	0.000232	0.000738	CcSEcCtD
Afatinib—ERBB2—Immune System—HLA-G—allergic rhinitis	0.000231	0.00146	CbGpPWpGaD
Afatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000231	0.00146	CbGpPWpGaD
Afatinib—Dizziness—Triamcinolone—allergic rhinitis	0.00023	0.000734	CcSEcCtD
Afatinib—Dizziness—Methylprednisolone—allergic rhinitis	0.00023	0.000732	CcSEcCtD
Afatinib—ERBB4—Immune System—HLA-G—allergic rhinitis	0.000228	0.00144	CbGpPWpGaD
Afatinib—Asthenia—Betamethasone—allergic rhinitis	0.000227	0.000722	CcSEcCtD
Afatinib—Asthenia—Dexamethasone—allergic rhinitis	0.000227	0.000722	CcSEcCtD
Afatinib—BLK—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000226	0.00142	CbGpPWpGaD
Afatinib—Nausea—Prednisolone—allergic rhinitis	0.000225	0.000716	CcSEcCtD
Afatinib—Pruritus—Dexamethasone—allergic rhinitis	0.000224	0.000712	CcSEcCtD
Afatinib—Pruritus—Betamethasone—allergic rhinitis	0.000224	0.000712	CcSEcCtD
Afatinib—LCK—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000222	0.0014	CbGpPWpGaD
Afatinib—Vomiting—Triamcinolone—allergic rhinitis	0.000221	0.000705	CcSEcCtD
Afatinib—Vomiting—Methylprednisolone—allergic rhinitis	0.000221	0.000704	CcSEcCtD
Afatinib—Nausea—Hydrocortisone—allergic rhinitis	0.00022	0.0007	CcSEcCtD
Afatinib—Rash—Triamcinolone—allergic rhinitis	0.00022	0.000699	CcSEcCtD
Afatinib—Dermatitis—Triamcinolone—allergic rhinitis	0.000219	0.000699	CcSEcCtD
Afatinib—BLK—Immune System—HLA-G—allergic rhinitis	0.000219	0.00138	CbGpPWpGaD
Afatinib—Rash—Methylprednisolone—allergic rhinitis	0.000219	0.000698	CcSEcCtD
Afatinib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000219	0.000697	CcSEcCtD
Afatinib—Headache—Triamcinolone—allergic rhinitis	0.000218	0.000695	CcSEcCtD
Afatinib—Headache—Methylprednisolone—allergic rhinitis	0.000218	0.000693	CcSEcCtD
Afatinib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000216	0.000689	CcSEcCtD
Afatinib—Diarrhoea—Betamethasone—allergic rhinitis	0.000216	0.000689	CcSEcCtD
Afatinib—ABL1—Cell Cycle—TGFB1—allergic rhinitis	0.000216	0.00136	CbGpPWpGaD
Afatinib—LCK—Host Interactions of HIV factors—CD4—allergic rhinitis	0.000209	0.00132	CbGpPWpGaD
Afatinib—Dizziness—Betamethasone—allergic rhinitis	0.000209	0.000666	CcSEcCtD
Afatinib—Dizziness—Dexamethasone—allergic rhinitis	0.000209	0.000666	CcSEcCtD
Afatinib—EGFR—Immune System—MS4A2—allergic rhinitis	0.000207	0.00131	CbGpPWpGaD
Afatinib—Nausea—Triamcinolone—allergic rhinitis	0.000207	0.000659	CcSEcCtD
Afatinib—Nausea—Methylprednisolone—allergic rhinitis	0.000206	0.000657	CcSEcCtD
Afatinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000206	0.0013	CbGpPWpGaD
Afatinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	0.000205	0.00129	CbGpPWpGaD
Afatinib—LCK—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000204	0.00129	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—IL5—allergic rhinitis	0.000201	0.00127	CbGpPWpGaD
Afatinib—Vomiting—Betamethasone—allergic rhinitis	0.000201	0.00064	CcSEcCtD
Afatinib—Vomiting—Dexamethasone—allergic rhinitis	0.000201	0.00064	CcSEcCtD
Afatinib—ERBB2—Signaling by NGF—NFKB1—allergic rhinitis	0.000201	0.00127	CbGpPWpGaD
Afatinib—LCK—Immune System—MS4A2—allergic rhinitis	0.0002	0.00126	CbGpPWpGaD
Afatinib—Rash—Betamethasone—allergic rhinitis	0.000199	0.000635	CcSEcCtD
Afatinib—Rash—Dexamethasone—allergic rhinitis	0.000199	0.000635	CcSEcCtD
Afatinib—Dermatitis—Betamethasone—allergic rhinitis	0.000199	0.000634	CcSEcCtD
Afatinib—Dermatitis—Dexamethasone—allergic rhinitis	0.000199	0.000634	CcSEcCtD
Afatinib—ABL1—Developmental Biology—ADIPOQ—allergic rhinitis	0.000199	0.00125	CbGpPWpGaD
Afatinib—Headache—Betamethasone—allergic rhinitis	0.000198	0.000631	CcSEcCtD
Afatinib—Headache—Dexamethasone—allergic rhinitis	0.000198	0.000631	CcSEcCtD
Afatinib—ERBB4—Signaling by NGF—NFKB1—allergic rhinitis	0.000198	0.00125	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000193	0.00122	CbGpPWpGaD
Afatinib—ABL1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000189	0.0012	CbGpPWpGaD
Afatinib—Nausea—Betamethasone—allergic rhinitis	0.000188	0.000598	CcSEcCtD
Afatinib—Nausea—Dexamethasone—allergic rhinitis	0.000188	0.000598	CcSEcCtD
Afatinib—ERBB2—Immune System—IL5—allergic rhinitis	0.000186	0.00118	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000185	0.00117	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-G—allergic rhinitis	0.000184	0.00116	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL5—allergic rhinitis	0.000184	0.00116	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000182	0.00115	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—CCL11—allergic rhinitis	0.000178	0.00113	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-G—allergic rhinitis	0.000178	0.00112	CbGpPWpGaD
Afatinib—BLK—Immune System—IL5—allergic rhinitis	0.000177	0.00112	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—CCL11—allergic rhinitis	0.000176	0.00111	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—NFKB1—allergic rhinitis	0.000175	0.00111	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—ICAM1—allergic rhinitis	0.000174	0.0011	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—ICAM1—allergic rhinitis	0.000171	0.00108	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.00017	0.00107	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—ADIPOQ—allergic rhinitis	0.00017	0.00107	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-G—allergic rhinitis	0.000167	0.00106	CbGpPWpGaD
Afatinib—LCK—Hemostasis—IL5—allergic rhinitis	0.000166	0.00105	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—ICAM1—allergic rhinitis	0.000165	0.00104	CbGpPWpGaD
Afatinib—EGFR—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000164	0.00104	CbGpPWpGaD
Afatinib—EGFR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	0.000162	0.00102	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000157	0.000991	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000151	0.000955	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.00015	0.000949	CbGpPWpGaD
Afatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000149	0.000943	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000149	0.000938	CbGpPWpGaD
Afatinib—IRAK1—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	0.000148	0.000932	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—CCL11—allergic rhinitis	0.000146	0.000922	CbGpPWpGaD
Afatinib—EPHA6—Developmental Biology—TGFB1—allergic rhinitis	0.000146	0.000922	CbGpPWpGaD
Afatinib—IRAK1—Signaling by NGF—NFKB1—allergic rhinitis	0.000145	0.000917	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HLA-DQB1—allergic rhinitis	0.000144	0.000911	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—SMAD3—allergic rhinitis	0.000144	0.000911	CbGpPWpGaD
Afatinib—PHKG2—Disease—CD4—allergic rhinitis	0.000144	0.00091	CbGpPWpGaD
Afatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	0.000144	0.000908	CbGpPWpGaD
Afatinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000142	0.0009	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HLA-DQB1—allergic rhinitis	0.000142	0.000898	CbGpPWpGaD
Afatinib—LCK—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	0.000137	0.000867	CbGpPWpGaD
Afatinib—BLK—Immune System—HLA-DQB1—allergic rhinitis	0.000137	0.000864	CbGpPWpGaD
Afatinib—LCK—HIV Infection—CD4—allergic rhinitis	0.000136	0.000858	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL5—allergic rhinitis	0.000135	0.000851	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000134	0.000847	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CYSLTR1—allergic rhinitis	0.000134	0.000843	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—CD4—allergic rhinitis	0.000133	0.000839	CbGpPWpGaD
Afatinib—EGFR—B Cell Activation—NFKB1—allergic rhinitis	0.000132	0.000833	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—CD4—allergic rhinitis	0.000131	0.000827	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-G—allergic rhinitis	0.000131	0.000826	CbGpPWpGaD
Afatinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000131	0.000825	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—NFKB1—allergic rhinitis	0.00013	0.000819	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TAC1—allergic rhinitis	0.00013	0.000819	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—CCL11—allergic rhinitis	0.000129	0.000815	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TAC1—allergic rhinitis	0.000128	0.000806	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—CD4—allergic rhinitis	0.000128	0.000806	CbGpPWpGaD
Afatinib—LCK—B Cell Activation—NFKB1—allergic rhinitis	0.000127	0.000802	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—CD4—allergic rhinitis	0.000126	0.000794	CbGpPWpGaD
Afatinib—EGFR—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000124	0.000781	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—SMAD3—allergic rhinitis	0.000123	0.000779	CbGpPWpGaD
Afatinib—ERBB2—Disease—SMAD3—allergic rhinitis	0.000121	0.000765	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—CD4—allergic rhinitis	0.000121	0.000764	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL5—allergic rhinitis	0.000121	0.000761	CbGpPWpGaD
Afatinib—ERBB4—Disease—SMAD3—allergic rhinitis	0.000119	0.000754	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL5—allergic rhinitis	0.000119	0.00075	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000115	0.000726	CbGpPWpGaD
Afatinib—ERBB2—Innate Immune System—NFKB1—allergic rhinitis	0.000115	0.000723	CbGpPWpGaD
Afatinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	0.000114	0.000721	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTGDR2—allergic rhinitis	0.000114	0.000719	CbGpPWpGaD
Afatinib—ERBB4—Innate Immune System—NFKB1—allergic rhinitis	0.000113	0.000712	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-G—allergic rhinitis	0.000112	0.000706	CbGpPWpGaD
Afatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	0.000112	0.000705	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HLA-DQB1—allergic rhinitis	0.000111	0.0007	CbGpPWpGaD
Afatinib—ERBB2—Adaptive Immune System—NFKB1—allergic rhinitis	0.00011	0.000694	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTGDR2—allergic rhinitis	0.00011	0.000693	CbGpPWpGaD
Afatinib—ERBB4—Adaptive Immune System—NFKB1—allergic rhinitis	0.000108	0.000684	CbGpPWpGaD
Afatinib—ERBB2—Developmental Biology—TGFB1—allergic rhinitis	0.000108	0.000682	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-G—allergic rhinitis	0.000108	0.00068	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—TAC1—allergic rhinitis	0.000106	0.00067	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL5—allergic rhinitis	0.000105	0.000666	CbGpPWpGaD
Afatinib—ERBB2—Immune System—ICAM1—allergic rhinitis	0.000105	0.000665	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HLA-DQB1—allergic rhinitis	0.000104	0.000659	CbGpPWpGaD
Afatinib—BLK—Adaptive Immune System—NFKB1—allergic rhinitis	0.000104	0.000658	CbGpPWpGaD
Afatinib—ERBB4—Immune System—ICAM1—allergic rhinitis	0.000104	0.000655	CbGpPWpGaD
Afatinib—PHKG2—Disease—TGFB1—allergic rhinitis	0.000103	0.000653	CbGpPWpGaD
Afatinib—BLK—Immune System—ICAM1—allergic rhinitis	9.98e-05	0.00063	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL5—allergic rhinitis	9.87e-05	0.000623	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—NFKB1—allergic rhinitis	9.71e-05	0.000613	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—CD4—allergic rhinitis	9.61e-05	0.000607	CbGpPWpGaD
Afatinib—LCK—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	9.58e-05	0.000605	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	9.51e-05	0.000601	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TAC1—allergic rhinitis	9.37e-05	0.000592	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—NFKB1—allergic rhinitis	9.35e-05	0.000591	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL5—allergic rhinitis	9.01e-05	0.000569	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CYSLTR1—allergic rhinitis	8.93e-05	0.000564	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL5—allergic rhinitis	8.72e-05	0.00055	CbGpPWpGaD
Afatinib—LCK—Immune System—IL5—allergic rhinitis	8.69e-05	0.000548	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CCL11—allergic rhinitis	8.63e-05	0.000545	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CYSLTR1—allergic rhinitis	8.61e-05	0.000544	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SMAD3—allergic rhinitis	8.48e-05	0.000536	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—ICAM1—allergic rhinitis	8.4e-05	0.00053	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SMAD3—allergic rhinitis	8.36e-05	0.000528	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CCL11—allergic rhinitis	8.31e-05	0.000525	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—NFKB1—allergic rhinitis	8.28e-05	0.000523	CbGpPWpGaD
Afatinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	8.17e-05	0.000516	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—ICAM1—allergic rhinitis	8.09e-05	0.000511	CbGpPWpGaD
Afatinib—ERBB2—Immune System—CD4—allergic rhinitis	7.74e-05	0.000489	CbGpPWpGaD
Afatinib—ERBB4—Immune System—CD4—allergic rhinitis	7.63e-05	0.000482	CbGpPWpGaD
Afatinib—IRAK1—Immune System—ICAM1—allergic rhinitis	7.62e-05	0.000481	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—CD4—allergic rhinitis	7.52e-05	0.000475	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	7.34e-05	0.000463	CbGpPWpGaD
Afatinib—BLK—Immune System—CD4—allergic rhinitis	7.34e-05	0.000463	CbGpPWpGaD
Afatinib—ERBB2—Disease—CD4—allergic rhinitis	7.15e-05	0.000451	CbGpPWpGaD
Afatinib—ERBB4—Disease—CD4—allergic rhinitis	7.04e-05	0.000445	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DQB1—allergic rhinitis	6.98e-05	0.000441	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	6.77e-05	0.000427	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DQB1—allergic rhinitis	6.73e-05	0.000425	CbGpPWpGaD
Afatinib—ERBB2—Immune System—NFKB1—allergic rhinitis	6.67e-05	0.000421	CbGpPWpGaD
Afatinib—ERBB4—Immune System—NFKB1—allergic rhinitis	6.57e-05	0.000415	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	6.48e-05	0.000409	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—CD4—allergic rhinitis	6.43e-05	0.000406	CbGpPWpGaD
Afatinib—BLK—Immune System—NFKB1—allergic rhinitis	6.32e-05	0.000399	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—NFKB1—allergic rhinitis	6.27e-05	0.000396	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TAC1—allergic rhinitis	6.27e-05	0.000396	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—CD4—allergic rhinitis	6.19e-05	0.000391	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—CD4—allergic rhinitis	6.17e-05	0.00039	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SMAD3—allergic rhinitis	6.13e-05	0.000387	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	6.11e-05	0.000386	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TAC1—allergic rhinitis	6.04e-05	0.000381	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	6e-05	0.000379	CbGpPWpGaD
Afatinib—ABL1—Immune System—ICAM1—allergic rhinitis	5.96e-05	0.000376	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—CD4—allergic rhinitis	5.95e-05	0.000375	CbGpPWpGaD
Afatinib—EGFR—Disease—SMAD3—allergic rhinitis	5.86e-05	0.00037	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL5—allergic rhinitis	5.83e-05	0.000368	CbGpPWpGaD
Afatinib—LCK—Disease—SMAD3—allergic rhinitis	5.64e-05	0.000356	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	5.64e-05	0.000356	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL5—allergic rhinitis	5.62e-05	0.000355	CbGpPWpGaD
Afatinib—IRAK1—Immune System—CD4—allergic rhinitis	5.6e-05	0.000353	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—NFKB1—allergic rhinitis	5.54e-05	0.00035	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—NFKB1—allergic rhinitis	5.34e-05	0.000337	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—NFKB1—allergic rhinitis	5.32e-05	0.000336	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—TGFB1—allergic rhinitis	5.22e-05	0.00033	CbGpPWpGaD
Afatinib—ERBB2—Disease—TGFB1—allergic rhinitis	5.13e-05	0.000324	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—NFKB1—allergic rhinitis	5.12e-05	0.000323	CbGpPWpGaD
Afatinib—EGFR—Immune System—ICAM1—allergic rhinitis	5.09e-05	0.000322	CbGpPWpGaD
Afatinib—ERBB4—Disease—TGFB1—allergic rhinitis	5.05e-05	0.000319	CbGpPWpGaD
Afatinib—LCK—Hemostasis—TGFB1—allergic rhinitis	4.94e-05	0.000312	CbGpPWpGaD
Afatinib—LCK—Immune System—ICAM1—allergic rhinitis	4.91e-05	0.00031	CbGpPWpGaD
Afatinib—IRAK1—Immune System—NFKB1—allergic rhinitis	4.82e-05	0.000304	CbGpPWpGaD
Afatinib—ABL1—Immune System—CD4—allergic rhinitis	4.38e-05	0.000277	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—NFKB1—allergic rhinitis	4.31e-05	0.000272	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—NFKB1—allergic rhinitis	4.25e-05	0.000268	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SMAD3—allergic rhinitis	4.1e-05	0.000259	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SMAD3—allergic rhinitis	3.95e-05	0.00025	CbGpPWpGaD
Afatinib—ABL1—Immune System—NFKB1—allergic rhinitis	3.77e-05	0.000238	CbGpPWpGaD
Afatinib—EGFR—Immune System—CD4—allergic rhinitis	3.74e-05	0.000236	CbGpPWpGaD
Afatinib—LCK—Immune System—CD4—allergic rhinitis	3.61e-05	0.000228	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—TGFB1—allergic rhinitis	3.59e-05	0.000227	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—TGFB1—allergic rhinitis	3.54e-05	0.000223	CbGpPWpGaD
Afatinib—EGFR—Disease—CD4—allergic rhinitis	3.46e-05	0.000218	CbGpPWpGaD
Afatinib—LCK—Disease—CD4—allergic rhinitis	3.33e-05	0.00021	CbGpPWpGaD
Afatinib—EGFR—Immune System—NFKB1—allergic rhinitis	3.22e-05	0.000204	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—NFKB1—allergic rhinitis	3.12e-05	0.000197	CbGpPWpGaD
Afatinib—LCK—Immune System—NFKB1—allergic rhinitis	3.11e-05	0.000196	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TGFB1—allergic rhinitis	2.6e-05	0.000164	CbGpPWpGaD
Afatinib—EGFR—Disease—TGFB1—allergic rhinitis	2.48e-05	0.000157	CbGpPWpGaD
Afatinib—LCK—Disease—TGFB1—allergic rhinitis	2.39e-05	0.000151	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NFKB1—allergic rhinitis	2.08e-05	0.000132	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NFKB1—allergic rhinitis	2.01e-05	0.000127	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TGFB1—allergic rhinitis	1.74e-05	0.00011	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TGFB1—allergic rhinitis	1.67e-05	0.000106	CbGpPWpGaD
